| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,293 |
6,293 |
$452K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,393 |
3,845 |
$256K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,111 |
2,734 |
$237K |
| S9083 |
Global fee urgent care centers |
1,835 |
1,636 |
$204K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,640 |
1,443 |
$115K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,938 |
2,145 |
$65K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,778 |
3,564 |
$59K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
691 |
388 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,671 |
2,489 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
970 |
733 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,782 |
2,832 |
$14K |
| 99205 |
Prolong outpt/office vis |
90 |
88 |
$9K |
| 99215 |
Prolong outpt/office vis |
66 |
64 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
66 |
62 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
24 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,329 |
800 |
$817.86 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
46 |
25 |
$589.47 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
33 |
14 |
$400.00 |
| 99051 |
|
39 |
34 |
$353.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
724 |
528 |
$302.98 |
| 81003 |
|
40 |
37 |
$37.59 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
169 |
158 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
79 |
52 |
$0.00 |
| 87807 |
|
22 |
12 |
$0.00 |